NCT03904121 is a clinical trial of Curative operation in Colon Cancer, sponsored by Tampere University Hospital.

Who is sponsoring NCT03904121?

NCT03904121 is sponsored by Tampere University Hospital.

What drugs are being tested in NCT03904121?

Interventions in NCT03904121: Curative operation.

What condition does NCT03904121 study?

NCT03904121 studies Colon Cancer.

Is NCT03904121 still recruiting?

NCT03904121 is currently completed. Last updated 12 April 2022.

Last reviewed 2022-04-12 · How we verify

NCT03904121

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Colon Cancer Surgery in the Aged; Postoperative Outcome, Functional Recovery and Survival.

Completed Last updated 12 April 2022

What this trial tests

trial testing Curative operation in Colon Cancer in 262 participants. Completed in 31 March 2022.

Timeline

1 April 2019

Primary endpoint
31 March 2021

31 March 2022

Quick facts

Lead sponsor	Tampere University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	262
Start date	1 April 2019
Primary completion	31 March 2021
Estimated completion	31 March 2022
Sites	1 location across Finland

Drugs / interventions tested

Curative operation

Conditions studied

Colon Cancer — all drugs for Colon Cancer →

Sponsor

Tampere University Hospital

Who can join

80 and older, any sex, with Colon Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients aged \> 80 years represent an increasing proportion of colon cancer diagnoses. It is important to have relevant and trustable data concerning elderly colorectal cancer patients surgery and postoperative morbidity, functional ability, life quality and survival numbers. With possibly compromised health status and functional decline the benefits of surgical management and outcomes can diminish life quality and overall survival. With proper patients selection, preoperative health evaluation and thus patient information, colorectal cancer surgery can be performed with lower morbidity and mortality rates with comparative survival numbers. The aim of this prospectively collected, observational study is to acquire data from colorectal cancer surgery in aged over 80 years and perform statistical analysis of the preoperative risk factors affecting postoperative morbidity, functional recovery, mortality and overall survival.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Surgical and functional outcomes and survival following Colon Cancer surgery in the aged: a study protocol for a prospective, observational multicentre study.
Niemeläinen S, Huhtala H, Ehrlich A, Kössi J, et al · · 2021 · cited 7× · PMID 34126949 · DOI 10.1186/s12885-021-08454-8
One-year functional outcomes of patients aged 80 years or more undergoing colonic cancer surgery: prospective, multicentre observational study.
Niemeläinen S, Huhtala H, Jämsen E, Kössi J, et al · · 2022 · cited 5× · PMID 35973109 · DOI 10.1093/bjsopen/zrac094
Clinical Frailty Scale predicts overall survival after colon cancer surgery in people aged 80 years and older: A prospective multicentre observational study.
Niemeläinen S, Hyöty M, Ehrlich A, Jämsen E, et al · · 2025 · cited 3× · PMID 40764923 · DOI 10.1111/codi.70190
Meta-Research in Geriatric Surgery: Improving the Quality of Surgical Evidence for Older Persons in a Multidimensional-Scale Research Field.
Lozada-Martinez ID, Hernandez-Paez DA, Palacios Velasco I, Martinez Guevara D, et al · · 2024 · cited 3× · PMID 39336933 · DOI 10.3390/jcm13185441

Verify or expand the search:

Other recruiting trials for Colon Cancer

Currently open trials in the same condition.

NCT06923787 — Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patient · Phase 2 · recruiting
NCT07279077 — Node-Sparing Low-Dose Radiotherapy Concurrent With Chemotherapy and PD-1 Inhibitor in pMMR/MSS High-Risk Locally Advance · Phase 2 · recruiting
NCT07205965 — The Effect of Acceptance and Commitment Approach-Based Psychoeducation in Cancer Survivors · NA · active not recruiting
NCT07285356 — Study to Evaluate the Use of Surgical Gloves for the Prevention of Oxaliplatin-Induced Peripheral Neuropathy · NA · recruiting
NCT07161713 — SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors · NA · recruiting

Other Tampere University Hospital trials

Trials by the same sponsor.

NCT07315568 — Couples and Microbial Diversity · not yet recruiting
NCT07128992 — Need-driven Treatment of the Patients With Type 1 Diabetes · not yet recruiting
NCT07042139 — No Reduction Compared to Closed Reduction for Distal Radius Fractures in Patients Over 65 or Older · NA · recruiting
NCT07528833 — Health Effects of Mindfulness Based Stress Reduction Course in Treatment of Back Pain · NA · recruiting
NCT06711796 — Measurement of Muscle Relaxation of the Hand in From Two Muscles and Two Hand Positions · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03904121 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Tampere University Hospital
Last refreshed: 12 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03904121.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing